Home
Indication Area
NRT
Pharma
Partners
Team
Press
CONTACT US
Home
Indication Area
NRT
Pharma
Partners
Team
Press
contact us
Home
Indication Area
NRT
Pharma
Partners
Team
Press
Home
Indication Area
NRT
Pharma
Partners
Team
Press
CONTACT US
Have a Project in Mind? Say Hi!
+1 800 123 456 789
+1 800 123 654 987
Mon - Sun: 10am - 10pm
27 Division St, New York,
NY 10002, USA
grido@mail.com
Press
October 3, 2022
Startup led by former Altria exec raises $17M to make inhaler for smokers who want to quit
Brian Quigley is the CEO of Richmond-based Qnovia, which is developing an inhaler-like device...
September 29, 2022
Qnovia: Pocket-Sized Vapor Nebulization
Every year, millions of cigarette smokers try to break their habit by turning to electronic...
September 28, 2022
Qnovia, Inc. Raises $17 Million in Series A Funding to Advance Its Inhalable Therapeutics Pipeline
LOS ANGELES–(BUSINESS WIRE)–Qnovia, Inc. (Qnovia), a pharma company developing inhaled...
September 16, 2022
‘Too many Respiras’: Smoking cessation health tech company throws out overused name as it rebrands to Qnovia
How do you deal with a problem like Respira? For this health tech company, which must compete with...
September 13, 2022
Respira Technologies, Inc. Rebrands as “QNOVIA”; Adopts Qnovia, Inc. as Corporate Name
LOS ANGELES–(BUSINESS WIRE)–Respira Technologies, Inc.—a clinical-stage company...
September 12, 2022
Respira Technologies Appoints CEO
Aerosol-focused biotech startup Respira Technologies is gearing up for the start of its first human...
#side-panel.side-panel {width: 500px;}#side-panel.side-panel .side-panel_sidebar {padding: 70px 0px 50px 60px;background-color: #FFFFFF;}
Qnovia